FDAsafety guidance83% confidence
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Vigonvita Life Sciences.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Metabolism · Oral Drug Delivery
- Sub-indication
- General
Related signal: VV913 Food Effect Study Initiated by Vigonvita Life Sciences